GPT and fibrosis: Impacted liver function was confirmed by observations of increased plasma levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in CCl4‐treated mice at the peak of fibrosis (i.e., ≈12 weeks) compared with control mice (Figure S1C), as expected and observed by others [35, 36].